Frankfurt - Delayed Quote EUR
Genflow Biosciences plc (WQ5.F)
0.0100
0.0000
(0.00%)
At close: May 30 at 3:29:02 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,082.2730
-1,082.2730
-1,660.8750
-1,368.3240
-747.3770
Investing Cash Flow
0
0
-2.4390
-2.4800
198.5020
Financing Cash Flow
656.6350
656.6350
0
3,499.5160
783.7110
End Cash Position
278.6820
278.6820
683.9740
2,356.2250
224.0040
Capital Expenditure
--
--
-2.4390
-2.4800
--
Issuance of Capital Stock
656.6350
656.6350
0
3,762.9200
783.7110
Issuance of Debt
--
--
--
0
0
Free Cash Flow
-1,082.2730
-1,082.2730
-1,663.3140
-1,370.8040
-747.3770
12/31/2021 - 2/2/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IPSC Century Therapeutics, Inc.
0.5304
-4.78%
BOLT Bolt Biotherapeutics, Inc.
0.3146
+0.19%
TLSA Tiziana Life Sciences Ltd
1.3600
-1.45%
BCLI Brainstorm Cell Therapeutics Inc.
1.1200
0.00%
CHRS Coherus BioSciences, Inc.
0.7790
-2.87%
PTIX Protagenic Therapeutics, Inc.
3.8500
+1.05%
EYEN Eyenovia, Inc.
1.6700
-7.73%
LXRX Lexicon Pharmaceuticals, Inc.
0.6266
-5.03%
CADL Candel Therapeutics, Inc.
5.45
-6.84%
ADMA ADMA Biologics, Inc.
19.84
+0.35%